Chris Takimoto
Chief Tech/Sci/R&D Officer chez IGM BIOSCIENCES, INC.
Fortune : 910 844 $ au 31/03/2024
Postes actifs de Chris Takimoto
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IGM BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 29/07/2021 | - |
Historique de carrière de Chris Takimoto
Anciens postes connus de Chris Takimoto
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/04/2020 | 01/07/2021 |
| FORTY SEVEN, INC. | Chief Tech/Sci/R&D Officer | 01/02/2016 | 01/04/2020 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 01/09/2010 | 01/01/2016 |
| Ortho Biotech Oncology Research & Development | Corporate Officer/Principal | 01/01/2008 | 01/01/2010 |
| University of Texas Health Science Center At San Antonio | Corporate Officer/Principal | 01/01/2000 | - |
Formation de Chris Takimoto
| Stanford University | Undergraduate Degree |
| Yale University | Doctorate Degree |
| Yale School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 5 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| IGM BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
| Ortho Biotech Oncology Research & Development | |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
- Bourse
- Insiders
- Chris Takimoto
- Expérience
